Covid 19 infections are surging nationally among Children according to doctors and kids now account for one in five new patients. And as those cases increased. So two cases of a rare but life threatening condition called M. I. S. C. Let's get the news center five Jessica brown. She's here to explain how researchers Jessica think that they're linked. You know what and public health officials in Italy where the first to notice a mysterious illness affecting Children. Weeks after the country experienced a sharp surge of COVID in April of 2020, the same cycle later repeated itself in other hotspots like London and New York City. That's when doctors made the connection. She just spiked a fever CC's temperature 103. Her mom Sarah couldn't knock it down. Kids get fevers, kids get rashes, you never know what's causing it. And then she noticed her daughter's hands and feet. So she went from being really really red to having complete blue and purple feet and uh hands and lips CC arrived at the emergency room tired and hot. She had a really rapid heart rate which was probably the scariest just weeks earlier, CC and her parents tested positive for Covid 19. Her dad developed mild symptoms. Cc and her mom had none. Once their quarantine ended. Sarah thought the danger for her family was over but Covid had triggered something else in CC. Called multi system inflammatory syndrome in Children also known as M. I. S. C. Or miss. See it is definitely an immune response. Doctor Adrian Randolph is a critical care specialist at boston Children's hospital currently collecting data for several federal studies. The hyper inflammatory response in part is because the immune system has never seen this virus before. M. I. S. C. Often appears about 3 to 6 weeks after a covid infection and can cause inflammation in a number of body parts including the heart, lungs, abdomen and brain. Even though it's very rare, affecting just three per 10,000 people under age 21 who are exposed to the virus. It appears to be more common in Children ages 6-12. About 70% of them end up in the intensive care unit with pediatric cases surging in the US since August and no vaccination authorized yet for kids under 12. Dr Randolph says she expects more M. I. S. C. Cases to emerge. We're watching very carefully and we anticipate that if it is going to peak it might be happening soon. In rare cases M. I. S. C. Can be fatal. But most patients do well with supportive care. While there's little data so far on long term complications especially involving the heart and brain. Doctor Randolph is optimistic. There's a long term solution. It's very likely that vaccination is going to prevent missy because then the patients already have antibodies and it's not their first exposure. Hopefully it will go away and we will see very few to no cases in the future. Well Pfizer announced yesterday that a smaller dose of its vaccine produces a strong antibody response in Children ages 5 to 11. So that solution to m i s c could arrive very soon. I'm Jessica Brown, WCVB News Center five.
>> COVID-19 INFECTIONS ARE SURGING NATIONALLY AMONG CHILENDR KIDS NOW ACCOUNT FOR ONE IN VE NEW PAEN.TI >> AND AS THOSE CASES INCREASE, SO DO CASES OF A RARE BUT LIFE-THREATENING CONDITION CALLED MC.IS NEWSCENTER 5’S JESSICA BROWN IS HERE TO EXPLAIN HOW RESEARCHERS THINK THEY’RE LKEIN >> PUBLIC HEALTH OFFICIA ILS ITALY WERE THE FIRST TO NOTICE A MYSTERIOUS ILLNESS AFFECTING CHILDREN WEEKS AFTER THE COUNTRY EXPERIENCED A SHARP SUOFE COVID IN APRIL OF 2020. TH E SAME CYCLE LATER REPEATED ITSELF IN OTHER HOT SPOTS, SUCH AS LONDON AND NEW YORK CITY. THAT’S WHEN DOCTORS MADE THE NNCOECTION. SHE JUST SPIKED A FEVER. CECE’S TEMPERATURE, 103. HER MOM SARAH COULDN’T KNOCK IT DOWN. KIDS GET FEVERS. KIDS GET RASS.HE YOU NEVER KNOW WT'H’S CAUSING IT. AND THEN SHE NOTICED HER DAUGHTER’S HANDS AND FEET. SHE WENT FROM BEING REALLY REALLY RED TO HAVING COMPLETYEL BLUE AND PURPLE FEET AND UH HANDS AND LIPS. CECE ARRIVED AT THE EMERGENCY ROOM, TIRED AND HOT. SHE HAD A REALLY RAPID HEART RATE, WHICH WAS POSSIBLY THE SCARIEST. JU ST WEEKS EARLIER, CECE AND HER PARENTS TESTED POSITIVE FOR COVID-19. HER DAD DEVELOPED MILD SYMPTOMS. CECE AND HER MOM HAD NONE. CEON THEIR QUARANTINED ENDED, SARAH THOUGHT THE DANGER FOR HER FAMILY WAS OVER. BUT COVID HAD TRIGGERED SOMETHING ELSE IN CECE CALLED MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN, ALSO KNOWN AS MISC OR MISS-C. IT IS DEFINITELY AN MUIM RESPSEON >> IT IS DEFINITELY AN IMMUNE RESPSEON DR. ADRIENNE RANDOLPH IS A CRITICAL CARE ECSPIALISTT A BOSTON CHILDREN’S HOSPITAL, CURRENTLY COLLECTING DATA FOR SEVERAL FEDERAL STUDIES. THE HYPER-INFLAMMATORY RESPONSE IS BECAUSE, IN PART, THE IMMUNE SYSTEM HAS NEVER SEETHN IS VIRUS BEFORE. MISC OFTEN APPEARS ABOUT 3-TO-6 WEEKS AFTER A COVID INFECTION, AND CAN CAUSE INFLAMMATION IN A NUMBER OF BODY PARTS, INCLUDING THE HEART, LUNGS, ABDOMEN AND BRAIN. pEVEN THOUGH IT’S VERY RARE, AFFECTING JUST 3 PER 10,000 PEOPLE UNDER AGE 21 WHO ARE EXPOSED TO THE VIRUS, AITPPEARS TO BE MORE COMMON IN CHILDREN AGES 6 TO 12. ABOUT 70% END UP IN THE INTENSIVE CARE UNIT. WITH PEDIATRIC CASES SURGING IN THE U.S. SINCE AUGUST, AND NO VACCINE AUTHORIZED YET FOR CHILDREN UNDER 12, DR. RANDOLPH SAYS SHE EXPECTS MORE MISC CASES TO EMERGE. WE’RE WATCHING VERY CAREFULLY AND WE ANTICIPATE IF IT’S GOING TO PEAK, IT MIGHT BE HAPPENING SOON. IN RARE CASES, MISC CAN BE FATAL, BUT MOST PATIENTS DO WELL WITH SUPPORTIVE CARE. WHILE THE'E’S LITTLE DATA SO FAR ON LONG-TERM COMPLICATIONS, ESPECIALLY INVOLVING THE HEART AND BRAIN, DR. RANDOLPH IS OPTIMISTIC THERE’S A LONG-TMER SOLUTI.ON IT’S VERY LIKELY ATTH CCVAINATION IS GOING TO PREVENT MIS-C BECAUSE THE PATIENT ALREADY HAS ANTIBODIES AND IT’S NOT THEIR FIRST EXPOSURE. AND HOPEFULLY IT WILL GO AWAY AND WE WILL SEE VERY FEW TO NO CASES IN THE FUTE.UR >> PFIZER ANNOUNCED YESTERDAY THAT A SMALLER DOSE OF

Rare, life-threatening condition MIS-C linked to children with COVID-19

Updated: 3:19 PM EDT Sep 22, 2021

Children now account for one in five new COVID-19 patients in the United States, and as pediatric coronavirus infections increase, so do cases of a rare but life-threatening condition.Sarah Fortunato says her daughter, Cece, "just spiked a fever." Cece's temperature was 103, but her mother couldn't knock it down."Kid's get fevers, kids get rashes," Sarah Fortunato said. "You never know what's causing it. She went from being really really red to having completely blue and purple feet and hands and lips. She had a really rapid heart rate, which was possibly the scariest."Cece arrived at the emergency room, tired and hot. Just weeks earlier, Cece and her parents tested positive for COVID-19. Her dad developed mild symptoms, but Cece and her mom had none.Once their quarantine ended, Sarah thought the danger for her family was over. But COVID-19 had triggered something else in Cece called multisystem inflammatory syndrome in children, also known as MIS-C.Dr. Adrienne Randolph, a critical care specialist at Boston Children's Hospital, is currently collecting data for several federal studies and says MIS-C is definitely an immune response."The hyper-inflammatory response is because, in part, the immune system has never seen this virus before," Randolph said.MIS-C often appears about three to six weeks after a COVID-19 infection and can cause inflammation in a number of body parts, including the heart, lungs, abdomen and brain.Even though it's very rare — affecting just three per 10,000 people under age 21 who are exposed to the virus — it appears to be more common in children ages 6 to 12."About 70% end up in the intensive care unit," Randolph said.With pediatric cases surging in the U.S. since August, and no vaccine authorized yet for children under the age of 12, Randolph said she expects more MIS-C cases to emerge."We're watching very carefully and we anticipate if it's going to peak, it might be happening soon," Randolph said.In rare cases, MIS-C can be fatal, but most patients do well with supportive care. While there is little data so far on long-term complications, especially involving the heart and brain, Randolph is optimistic there is a long-term solution."It's very likely that vaccination is going to prevent MIS-C because the patient already has antibodies and it's not their first exposure," Randolph said. "And hopefully it will go away and we will see very few to no cases in the future."Pfizer announced Monday that a smaller dose of its vaccine produces a strong antibody response in children ages 5 to 11, so that solution to MIS-C could arrive very soon.

BOSTON —

Children now account for one in five new COVID-19 patients in the United States, and as pediatric coronavirus infections increase, so do cases of a rare but life-threatening condition.

Sarah Fortunato says her daughter, Cece, "just spiked a fever." Cece's temperature was 103, but her mother couldn't knock it down.

"Kid's get fevers, kids get rashes," Sarah Fortunato said. "You never know what's causing it. She went from being really really red to having completely blue and purple feet and hands and lips. She had a really rapid heart rate, which was possibly the scariest."

Cece arrived at the emergency room, tired and hot. Just weeks earlier, Cece and her parents tested positive for COVID-19. Her dad developed mild symptoms, but Cece and her mom had none.

Once their quarantine ended, Sarah thought the danger for her family was over. But COVID-19 had triggered something else in Cece called multisystem inflammatory syndrome in children, also known as MIS-C.

Dr. Adrienne Randolph, a critical care specialist at Boston Children's Hospital, is currently collecting data for several federal studies and says MIS-C is definitely an immune response.

"The hyper-inflammatory response is because, in part, the immune system has never seen this virus before," Randolph said.

MIS-C often appears about three to six weeks after a COVID-19 infection and can cause inflammation in a number of body parts, including the heart, lungs, abdomen and brain.

Even though it's very rare — affecting just three per 10,000 people under age 21 who are exposed to the virus — it appears to be more common in children ages 6 to 12.

"About 70% end up in the intensive care unit," Randolph said.

With pediatric cases surging in the U.S. since August, and no vaccine authorized yet for children under the age of 12, Randolph said she expects more MIS-C cases to emerge.

"We're watching very carefully and we anticipate if it's going to peak, it might be happening soon," Randolph said.

In rare cases, MIS-C can be fatal, but most patients do well with supportive care. While there is little data so far on long-term complications, especially involving the heart and brain, Randolph is optimistic there is a long-term solution.

"It's very likely that vaccination is going to prevent MIS-C because the patient already has antibodies and it's not their first exposure," Randolph said. "And hopefully it will go away and we will see very few to no cases in the future."

Pfizer announced Monday that a smaller dose of its vaccine produces a strong antibody response in children ages 5 to 11, so that solution to MIS-C could arrive very soon.